Robbinsville, NJ, United States of America

Syed Asfar Mateen

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Syed Asfar Mateen: Innovator in Pharmaceutical Formulations

Introduction

Syed Asfar Mateen is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 5 patents to his name, he has established himself as a key figure in pharmaceutical research and development.

Latest Patents

Among his latest patents, Syed has developed formulations for centanafadine, a pharmaceutical compound. His patents include detailed methods of making and using centanafadine pharmaceutical formulations, which comprise centanafadine or a pharmaceutically acceptable salt thereof along with an excipient. These formulations and their related methods of manufacture and use are crucial for advancing therapeutic options in the pharmaceutical industry.

Career Highlights

Syed Asfar Mateen is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field. His work focuses on enhancing the efficacy and safety of pharmaceutical products, which is vital for patient care and treatment outcomes.

Collaborations

Throughout his career, Syed has collaborated with talented professionals in the industry, including Praveen Kumar Mididoddi and Shailly Mehrotra. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Syed Asfar Mateen's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work not only advances scientific knowledge but also improves the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…